Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis

Pharmaceutics
Qingliang KongMasahiro Goto

Abstract

Japanese cedar pollinosis (JCP) is a common affliction caused by an allergic reaction to cedar pollen and is considered a disease of national importance in Japan. Antigen-specific immunotherapy (AIT) is the only available curative treatment for JCP. However, low compliance and persistence have been reported among patients subcutaneously or sublingually administered AIT comprising a conventional antigen derived from a pollen extract. To address these issues, many research studies have focused on developing a safer, simpler, and more effective AIT for JCP. Here, we review the novel antigens that have been developed for JCP AIT, discuss their different administration routes, and present the effects of anti-allergy treatment. Then, we describe a new form of AIT called transcutaneous immunotherapy (TCIT) and its solid-in-oil (S/O) nanodispersion formulation, which is a promising antigen delivery system. Finally, we discuss the applications of S/O nanodispersions for JCP TCIT. In this context, we predict that TCIT delivery by using a S/O nanodispersion loaded with novel antigens may offer an easier, safer, and more effective treatment option for JCP patients.

References

Jan 1, 1983·The Journal of Allergy and Clinical Immunology·H YasuedaT Shida
Sep 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M HashimotoT Ogawa
Jun 6, 2000·Experimental Dermatology·J D Bos, M M Meinardi
Jul 26, 2003·The Journal of Investigative Dermatology·Kathi C Madison
Dec 4, 2003·Bioscience, Biotechnology, and Biochemistry·Masakatsu UsuiAkio Kato
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anu ImmonenTuomas Virtanen
Dec 19, 2006·Plant Biotechnology Journal·Hidenori TakagiFumio Takaiwa
Sep 27, 2007·Pharmaceutical Research·Hongyu PiaoMasahiro Goto
Oct 30, 2007·Allergology International : Official Journal of the Japanese Society of Allergology·Masako TsunematsuKohsuke Kino
May 20, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Naoya KojimaKunio Tsujimura
Aug 9, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshiro TaharaMasahiro Goto
Aug 26, 2009·The Journal of Allergy and Clinical Immunology·Kei-ichi YamanakaHitoshi Mizutani
Oct 30, 2010·Chemical Communications : Chem Comm·Yoshiro TaharaMasahiro Goto
Jan 14, 2011·Auris, Nasus, Larynx·Masahiro SakaguchiMasako Toda
Mar 7, 2013·International Journal of Pharmaceutics·Majella E Lane
Apr 9, 2013·Colloids and Surfaces. B, Biointerfaces·Madalena MartinsArtur Cavaco-Paulo
May 9, 2013·The Journal of Allergy and Clinical Immunology·Menno A KielMaureen P M H Rutten-van Mölken
Dec 24, 2013·The Journal of Allergy and Clinical Immunology·Takechiyo YamadaShigeharu Fujieda
Mar 4, 2014·Current Dermatology Reports·Szun S TayWolfgang Weninger
Apr 4, 2015·Allergology International : Official Journal of the Japanese Society of Allergology·Daisuke MurakamiShizuo Komune
Sep 8, 2015·Protein and Peptide Letters·Madalena MartinsArtur Cavaco-Paulo
Oct 5, 2015·Allergology International : Official Journal of the Japanese Society of Allergology·Takashi Fujimura, Seiji Kawamoto
Jan 16, 2016·Current Allergy and Asthma Reports·Robyn E O'HehirJennifer M Rolland
Aug 17, 2016·Biotechnology Journal·Momoko KitaokaMasahiro Goto
Nov 21, 2016·Journal of Pharmaceutical Sciences·Shashank JainNamrata Vora
Feb 1, 2017·Expert Opinion on Investigational Drugs·Peter A RickettiThomas B Casale

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
confocal microscopy

Clinical Trials Mentioned

NCT03101267

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2021 Meta ULC. All rights reserved